Insider filing · MRNA
James M Mock
Chief Financial Officer
profile →
Moderna, Inc.
MRNA · Healthcare · 18 filings in 24 months
ticker →
James M Mock sold $4.7M of Moderna (MRNA)
Executed Sep 10, disclosed Sep 14, 4 days later.
Value, as filed
$4.7M
34,836 sh across 2 lots
Executed
Sep 10
the trade date, as filed
Disclosed
Sep 14
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JMJames M Mock (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Moderna, Inc. (MRNA). The largest single filing was $4.7M of MRNA (34,836 sh across 2 lots, as filed), executed Sep 10.
The name
MRNAHealthcare · Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→